Company intelligence / Profile preview

Enzymes.bio

Wuhan, China

Ownership: Private
Development stage: Other

Overview

Enzymes.bio is a specialized biotechnology company focused on the supply and distribution of high-quality industrial and research-grade enzymes. The company provides a wide array of enzymatic products catering to diverse sectors including food processing, animal feed, textiles, and pharmaceutical manufacturing. Their portfolio includes carbohydrases, proteases, and lipases designed to optimize industrial processes and improve product yields. Beyond product supply, Enzymes.bio offers technical support and consultation to help clients integrate enzymatic solutions into their specific production workflows.

Modalities: EnzymeProtein
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Enzymes.bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enzymes.bio.

Explore the full profile